bluebird bio, Inc. (BLUE) — Analyst outlook / Analyst consensus target is. Based on 37 analyst ratings, the consensus is bullish — 14 Buy, 19 Hold, 4 Sell.
The consensus price target is $13.69 (low: $5.00, high: $25.00), representing an upside of 175.5% from the current price $4.97.
BLUE Stock — 12-Month Price Forecast
$13.69
▲ +175.45% Upside
Average Price Target
Based on 37 Wall Street analysts offering 12-month price targets for bluebird bio, Inc., the average price target is $13.69, with a high forecast of $25.00, and a low forecast of $5.00.
The average price target represents a +175.45% change from the last price of $4.97.
Highest Price Target
$25.00
Average Price Target
$13.69
Lowest Price Target
$5.00
BLUE Analyst Ratings
Hold
Based on 37 analysts giving stock ratings to bluebird bio, Inc. in the past 3 months
